Healthcare counsel with an insider's perspective

Amy Cotton Peterson helps entities in the healthcare industry navigate the labyrinth of laws and regulations governing their operations and evolving businesses. With deep knowledge of constantly evolving technologies, service models and clients' business needs, she advises on:

Healthcare transactions, representing buyers, sellers and investors in all aspects of the sale or purchase of healthcare entities.

Regulatory compliance, advising on federal and state regulations governing licensure, privacy, Medicaid and Medicare reimbursement, clinical trials, provider self-referral and false claims.

Provider defense, representing and defending providers before professional licensing boards and state and federal regulatory agencies.

Business operations and development, counseling clients through internal and remedial investigations and obtaining regulatory approval for novel business initiatives.

As a former licensed physical therapist, Amy brings an inside-the-industry perspective to the legal and regulatory issues facing providers and related entities.

Bar Admissions
Arizona

Education
A.T. Still University (M.S.P.T., 1999)

Harvard Law School Executive Education

Pepperdine Caruso School of Law (J.D., 2005)

CALI Future Excellence Award, Entertainment Law

Truman State University (B.S., cum laude, 1996)

"Concerns Over Drug Compounding Bills on Capitol Hill" "Emerging Issues in Specialty Pharmacy" "Health Care Changes Under President Trump" "Hot Topics in Pharmacy Law" "How Can a Physical Therapist Avoid Common Mistakes When Responding to a P.T. Board Investigation?" "Implementation of an Effective Compliance Plan" "Industry/Business of Pharmacy" "Legal Issues in Specialty Pharmacy" "New and Improved? - A Discussion of New and Proposed State Regulations" "Specialty Pharmacy and the Law" "The Ethics of Personalized Medicine" "What's New in Pharmacy?" A Welcome Goodbye: Congress Repeals $2,010 Therapy Cap Amy Cotton Peterson, Jon Howard Write Healthcare Business Today Article About Growing Private Equity Presence in Medical Spa Industry April is National Autism Awareness Month California Cracks Down: New Laws Governing the Corporate Practice of Medicine and PE Deals California Follows the Lead of Other States in Heightening the Scrutiny of Health Care Transactions California's Pre-Closing Health Care Transaction Review Regulations Take Effect: Where Did We Land? Is Your Fitbit FDA-Legit? Kentucky Board of Pharmacy Continues to Research and Review Proposed Non-Resident Pharmacy Permit Regulations Kentucky Board of Pharmacy Regulation Committee Proposes New Requirement of Licensure for All Out-of-State Pharmacists Med Spa Compliance Series: Area of Focus - Criminal Consequences of Noncompliance Med Spa Compliance Series: Area of Focus - Good Faith Examination Med Spa Compliance Series: Area of Focus - Proposed Med Spa Facility Licensure Requirements in Iowa and Indiana Med Spa Compliance Series: Area of Focus - Scope of Practice and Supervising Physician Compliance New DOJ Policy for M&A Transactions Promotes Thorough Due Diligence and Voluntary Self-Disclosures Oregon Enacts Legislation Placing Parameters on PE Involvement in Professional Medical Entities PE in Healthcare - Recent Governmental Commentary Could Indicate Policy Changes on the Horizon and Time for Increased Vigilance Pharmacy Law Trends Q&A: Opioids, Specialty Drugs Among Top Issues for Retail Pharmacies Pharmacy Law: Technology Issues Faced by Pharmacies Across the Country Private Equity Groups and Hedge Funds - Be Aware of Proposed California Legislation Potentially Imposing Further Approval Requirements and Restrictions on Certain Health Care Transactions Proposed Legislation Indicative of Continued Congressional Efforts to Expand PBM Oversight Safeway Prevails on Motion for Summary Judgment in Whistleblower Pharmacy Usual and Customary Pricing Case Senate Sets Sights on Drug Compounding: But Does it Solve the Problems? Telepharmacy, Telemedicine, AIC, and Other Alternative Sites of Care The California Legislature Revisits Limitations on and Oversight of PE Involvement in the Health Care Industry ​U.S. Supreme Court Rules that State Licensing Board Is Not Immune From Anti-Trust Claims